Dr Cash confirmed to Dr Mitchell that "the WBTS should undertake, on behalf of the SNBTS, initial evaluation studies of commercial HTLV-III antibody kits, but current pressure from commercial organisations to meet their deadlines should be resisted and priority given to SNBTS interests."
Linked evidence
Chronology Information
Date:
Chapter/issue
HIV Screening
Key Person(s)
Professor John D Cash
Dr Ruthven Mitchell